Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.26
(-3.4%)
CNY 4.26
(-3.4%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 593.88 Million CNY | -0.82% |
| 2022 | 598.81 Million CNY | -31.45% |
| 2021 | 873.52 Million CNY | -38.62% |
| 2020 | 1.42 Billion CNY | -16.07% |
| 2019 | 1.69 Billion CNY | -4.19% |
| 2018 | 1.76 Billion CNY | -1.91% |
| 2017 | 1.8 Billion CNY | -8.85% |
| 2016 | 1.97 Billion CNY | 192.25% |
| 2015 | 677.25 Million CNY | 26.35% |
| 2014 | 536 Million CNY | 129.48% |
| 2013 | 233.57 Million CNY | -21.11% |
| 2012 | 296.07 Million CNY | -9.68% |
| 2011 | 327.8 Million CNY | -1.8% |
| 2010 | 333.8 Million CNY | -9.98% |
| 2009 | 370.81 Million CNY | 1.04% |
| 2008 | 367.01 Million CNY | -9.47% |
| 2007 | 405.41 Million CNY | 13.03% |
| 2006 | 358.67 Million CNY | -4.87% |
| 2005 | 377.05 Million CNY | -0.67% |
| 2004 | 379.58 Million CNY | 11.45% |
| 2003 | 340.58 Million CNY | 44.88% |
| 2002 | 235.08 Million CNY | 278.67% |
| 2001 | 62.08 Million CNY | -50.17% |
| 2000 | 124.58 Million CNY | -24.71% |
| 1999 | 165.47 Million CNY | 414.17% |
| 1998 | 32.18 Million CNY | 57.35% |
| 1997 | 20.45 Million CNY | 2.16% |
| 1996 | 20.02 Million CNY | 39.03% |
| 1995 | 14.4 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 567.77 Million CNY | -50.6% |
| 2024 Q1 | 590.45 Million CNY | -0.58% |
| 2024 Q2 | 587.93 Million CNY | -0.43% |
| 2023 Q4 | 593.88 Million CNY | 2.03% |
| 2023 Q3 | 582.05 Million CNY | -1.26% |
| 2023 Q2 | 589.47 Million CNY | -1.07% |
| 2023 FY | 593.88 Million CNY | -0.82% |
| 2023 Q1 | 595.82 Million CNY | -0.5% |
| 2022 Q3 | 704.39 Million CNY | -9.6% |
| 2022 Q4 | 598.81 Million CNY | -14.99% |
| 2022 FY | 598.81 Million CNY | -31.45% |
| 2022 Q1 | 790.53 Million CNY | -9.5% |
| 2022 Q2 | 779.17 Million CNY | -1.44% |
| 2021 Q4 | 873.52 Million CNY | -28.72% |
| 2021 Q1 | 1.27 Billion CNY | -10.18% |
| 2021 FY | 873.52 Million CNY | -38.62% |
| 2021 Q2 | 1.23 Billion CNY | -3.1% |
| 2021 Q3 | 1.22 Billion CNY | -1.05% |
| 2020 Q3 | 1.47 Billion CNY | -5.46% |
| 2020 Q1 | 1.77 Billion CNY | 4.66% |
| 2020 Q2 | 1.56 Billion CNY | -12.0% |
| 2020 Q4 | 1.42 Billion CNY | -3.61% |
| 2020 FY | 1.42 Billion CNY | -16.07% |
| 2019 Q3 | 2.32 Billion CNY | 28.52% |
| 2019 Q1 | 1.71 Billion CNY | -3.15% |
| 2019 FY | 1.69 Billion CNY | -4.19% |
| 2019 Q4 | 1.69 Billion CNY | -27.02% |
| 2019 Q2 | 1.8 Billion CNY | 5.48% |
| 2018 Q4 | 1.76 Billion CNY | 4.99% |
| 2018 FY | 1.76 Billion CNY | -1.91% |
| 2018 Q2 | 1.6 Billion CNY | 1.23% |
| 2018 Q1 | 1.58 Billion CNY | -12.0% |
| 2018 Q3 | 1.68 Billion CNY | 4.89% |
| 2017 Q2 | 2.13 Billion CNY | 6.03% |
| 2017 Q1 | 2 Billion CNY | 1.5% |
| 2017 FY | 1.8 Billion CNY | -8.85% |
| 2017 Q4 | 1.8 Billion CNY | -15.34% |
| 2017 Q3 | 2.13 Billion CNY | 0.03% |
| 2016 Q1 | 1.2 Billion CNY | 77.48% |
| 2016 Q3 | 1.12 Billion CNY | 0.18% |
| 2016 Q2 | 1.12 Billion CNY | -6.69% |
| 2016 Q4 | 1.97 Billion CNY | 76.16% |
| 2016 FY | 1.97 Billion CNY | 192.25% |
| 2015 Q1 | 598 Million CNY | 11.57% |
| 2015 Q3 | 634.45 Million CNY | 3.25% |
| 2015 FY | 677.25 Million CNY | 26.35% |
| 2015 Q2 | 614.45 Million CNY | 2.75% |
| 2015 Q4 | 677.25 Million CNY | 6.75% |
| 2014 FY | 536 Million CNY | 129.48% |
| 2014 Q1 | 247.67 Million CNY | 6.04% |
| 2014 Q2 | 251.57 Million CNY | 1.57% |
| 2014 Q3 | 251.57 Million CNY | 0.0% |
| 2014 Q4 | 536 Million CNY | 113.06% |
| 2013 Q3 | 296.07 Million CNY | 0.0% |
| 2013 Q1 | 296.07 Million CNY | 0.0% |
| 2013 Q2 | 296.07 Million CNY | 0.0% |
| 2013 Q4 | 233.57 Million CNY | -21.11% |
| 2013 FY | 233.57 Million CNY | -21.11% |
| 2012 FY | 296.07 Million CNY | -9.68% |
| 2012 Q4 | 296.07 Million CNY | 0.0% |
| 2012 Q3 | 296.07 Million CNY | 0.0% |
| 2012 Q2 | 296.07 Million CNY | -9.68% |
| 2012 Q1 | 327.8 Million CNY | 0.0% |
| 2011 FY | 327.8 Million CNY | -1.8% |
| 2011 Q1 | 332.8 Million CNY | -0.3% |
| 2011 Q2 | 327.8 Million CNY | -1.5% |
| 2011 Q4 | 327.8 Million CNY | 0.0% |
| 2011 Q3 | 327.8 Million CNY | 0.0% |
| 2010 Q3 | 340.21 Million CNY | -7.25% |
| 2010 FY | 333.8 Million CNY | -9.98% |
| 2010 Q4 | 333.8 Million CNY | -1.89% |
| 2010 Q2 | 366.81 Million CNY | -1.08% |
| 2010 Q1 | 370.81 Million CNY | 0.0% |
| 2009 Q3 | 364.63 Million CNY | -1.63% |
| 2009 FY | 370.81 Million CNY | 1.04% |
| 2009 Q4 | 370.81 Million CNY | 1.7% |
| 2009 Q1 | 371.3 Million CNY | 1.17% |
| 2009 Q2 | 370.68 Million CNY | -0.17% |
| 2008 Q3 | 384.21 Million CNY | -0.92% |
| 2008 FY | 367.01 Million CNY | -9.47% |
| 2008 Q1 | 405.41 Million CNY | 0.0% |
| 2008 Q2 | 387.78 Million CNY | -4.35% |
| 2008 Q4 | 367.01 Million CNY | -4.48% |
| 2007 Q3 | 297.31 Million CNY | -8.04% |
| 2007 Q2 | 323.31 Million CNY | 0.69% |
| 2007 Q4 | 405.41 Million CNY | 36.36% |
| 2007 FY | 405.41 Million CNY | 13.03% |
| 2007 Q1 | 321.11 Million CNY | -10.47% |
| 2006 Q3 | 357.18 Million CNY | -4.52% |
| 2006 Q1 | 368.48 Million CNY | -2.27% |
| 2006 FY | 358.67 Million CNY | -4.87% |
| 2006 Q4 | 358.67 Million CNY | 0.42% |
| 2006 Q2 | 374.1 Million CNY | 1.53% |
| 2005 Q4 | 377.05 Million CNY | -4.48% |
| 2005 Q3 | 394.73 Million CNY | 4.54% |
| 2005 Q2 | 377.59 Million CNY | -0.72% |
| 2005 Q1 | 380.32 Million CNY | 0.19% |
| 2005 FY | 377.05 Million CNY | -0.67% |
| 2004 Q3 | 217.58 Million CNY | 0.0% |
| 2004 Q1 | 186.58 Million CNY | -45.22% |
| 2004 FY | 379.58 Million CNY | 11.45% |
| 2004 Q2 | 217.58 Million CNY | 16.61% |
| 2004 Q4 | 379.58 Million CNY | 74.46% |
| 2003 Q3 | - CNY | -100.0% |
| 2003 Q2 | 241.08 Million CNY | 0.0% |
| 2003 FY | 340.58 Million CNY | 44.88% |
| 2003 Q4 | 340.58 Million CNY | 0.0% |
| 2003 Q1 | - CNY | -100.0% |
| 2002 Q2 | 138.08 Million CNY | 0.73% |
| 2002 FY | 235.08 Million CNY | 278.67% |
| 2002 Q1 | 137.08 Million CNY | 120.81% |
| 2002 Q3 | 159.08 Million CNY | 15.21% |
| 2002 Q4 | 235.08 Million CNY | 47.77% |
| 2001 FY | 62.08 Million CNY | -50.17% |
| 2001 Q4 | 62.08 Million CNY | 0.0% |
| 2001 Q2 | 86.58 Million CNY | 0.0% |
| 2000 Q4 | 124.58 Million CNY | 0.0% |
| 2000 FY | 124.58 Million CNY | -24.71% |
| 2000 Q2 | 133.18 Million CNY | 0.0% |
| 1999 Q2 | 40.18 Million CNY | 0.0% |
| 1999 FY | 165.47 Million CNY | 414.17% |
| 1999 Q4 | 165.47 Million CNY | 0.0% |
| 1998 FY | 32.18 Million CNY | 57.35% |
| 1998 Q4 | 32.18 Million CNY | 0.0% |
| 1997 FY | 20.45 Million CNY | 2.16% |
| 1996 FY | 20.02 Million CNY | 39.03% |
| 1995 FY | 14.4 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.54 Billion CNY | 76.646% |
| Zhejiang Zhenyuan Share Co., Ltd. | 138.12 Million CNY | -329.944% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 935.85 Million CNY | 36.542% |
| Yifan Pharmaceutical Co., Ltd. | 1.99 Billion CNY | 70.234% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 4.36 Million CNY | -13503.303% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.55 Billion CNY | 92.14% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 273.99 Million CNY | -116.746% |
| Boai NKY Medical Holdings Ltd. | 60.4 Million CNY | -883.113% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 62.44 Million CNY | -851.076% |